Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine

Depressive Disorders; Fluoxetine; Tianeptine; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Thiazepines; Treatment Outcome

Abstract :

[en] Background: Depression is treated by a great variety of antidepressant treatments. SSRIs (such as fluoxetine) are well known: it is, however, sure that further progress is needed and the search for antidepressants with other mechanisms of action (such as tianeptine) or different efficacy is still of interest. Methods: A multinational study compared tianeptine with fluoxetine in 387 patients with Depressive Episode, or Recurrent Depressive Disorder, or Bipolar Affective Disorder (ICD-10), in a double-blind parallel group design. They were treated for six weeks. Results: At inclusion, no significant difference between groups was shown. Final MADRS scores were 15.7 and 15.8 with tianeptine and fluoxetine, respectively (ITT population) (p=0.944). MADRS responders were 58% and 56% with tianeptine and fluoxetine, respectively (p=0.710). No statistical difference was observed for the other efficacy parameters. Thirty-six withdrawals occurred in each group, without any difference for the reasons of discontinuation. There was no major difference between groups for the other safety parameters. Conclusions: In this study, both tianeptine and fluoxetine exhibited a good efficacy and safety. Copyright (C) 1999 Elsevier Science B.V.

Disciplines :

Treatment & clinical psychology

Author, co-author :

Lôo, H.; Serv. Hosp. Univ. S. Mentale T., Sainte-Anne Hosp., 7 R. C., Paris, France

Saiz-Ruiz, J.; Ramon Y Cajal Hospital, Department of Psychiatry, Madrid, Spain

Costa E Silva, J. A.; University Hospital, Faculty of Medicine, Rio de Janeiro, Brazil

ANSSEAU, Marc ; Université de Liège - ULg

Herrington, R.; Gartnavel Royal Hospital, Scotland, Glasgow, United Kingdom

Vaz-Serra, A.; University Hospital, Department of Psychiatry, Coimbra, Portugal

Dilling, H.; University Hospital, Clinic of Psychiatry, Lübeck, Germany

De Risio, S.; Catholic University del Sacro Cuore, Inst. of Psychiatry and Psychology, Roma, Italy

Language :

English

Title :

Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine

Publication date :

1999

Journal title :

Journal of Affective Disorders

ISSN :

0165-0327

eISSN :

1573-2517

Publisher :

Elsevier, Netherlands

Volume :

Issue :

2-3

Pages :

109-118

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 30 August 2021

Statistics

Number of views

85 (2 by ULiège)

Number of downloads

101 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Alby J.M., Ferreri M., Cabane J., de Bodinat C., Dagens V. Efficacité de la tianeptine (STABLON ®) dans le traitement des dépressions majeures et des dysthymies, avec plaintes somatiques. Etude comparée versus fluoxétine (PROZAC®). Ann. Psychiatrie. 8:(2):1993;136-144.
Bobon D.P. Le système AMDP. in. Psycho. Sci. Hum. 2e éd. coll :1981;Mardaga, Bruxelles.
Chamba G., Lemoine P., Flachaire E., Ferry N., Quincy C., Sassard J., Ferber C., Mocaër E., Kamoun A., Renaud B. Increased serotonin platelet uptake after tianeptine administration in depressed patients. Biol. Psychiatry. 30:1991;609-617.
Chapuy P., Cuny G., Delomier Y., Galley P., Michel J.P., Pareaud M., Marey C. La dépression du sujet âgé. Íntérât de la tianeptine chez 140 patients traités pendant un an. Presse Med. 20:(37):1991;1844-1852.
Delalleau B., Dulcire C., Le Moine P., Kamoun A. Analysis of the side-effects of tianeptine. Clin. Neuropharmacol. 11:(suppl 2):1988;S83-S89.
Faravelli C., Servi P., Arends J.A., Strik W.K. Number of symptoms, Quantification, and Qualification of Depression. Compr. Psychiatry. 37:(5):1996;307-315.
Gross G., Huber G. Depressive or Mood Disorders in Operationalized Classification Systems and the Affective Psychoses (Manic-Depressive Illness, Cyclothymia) of the Traditional Psychiatry. A critical review. Neurology, Psychiatry and Brain Res. 4:1996;149-158.
Guelfi J.D. Efficacy of tianeptine in comparative trials versus reference antidepressants: an overview. Br. J. Psychiatry. 160:(suppl 15):1992;72-75.
Guelfi J.D., Dulcire C., Le Moine P., Tafani A. Clinical safety and efficacy of tianeptine in 1858 depressed patients treated in general practice. Neuropsychobiology. 25:1992;140-148.
Guelfi J.D., Pichot P., Dreyfus J.F. Efficacy of tianeptine in anxious-depressed patients: Results of a controlled multicenter trial versus amitriptyline. Neuropsychobiology. 22:1989;41-48.
Hamdi E., Amin Y., Abou-Saleh M.T. Problems in validating endogenous depression in the Arab culture by contemporary diagnostic criteria. J. Affect. Disord. 44:1997;131-143.
Hiller W., Dichtl G., Hecht H., Hundt W., Mombourg W., von Zerssen D. Evaluating the new ICD-10 categories of depressive episode and recurrent depressive disorder. J. Affect. Disord. 31:1994;49-60.
Invernizzi G., Aguglia E., Bertolino A., Casacchia M., Ciani N., Marchesi G.F., Nardini M., Rapisarda V. The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study versus amitriptyline. Neuropsychobiology. 30:1994;85-93.
Kato G., Weitsch A.F. Neurochemical profile of tianeptine a new antidepressant drug. Clinical Neuropharmacology. 11:(suppl 2):1988;S43-S50.
Kelly J.P., Leonard B.E. The effect of tianeptine on the olfactory bulbectomized (OB) rat model of depression. IIIrd International Congress of European Behavioural Pharmacology Meeting, Noordwigkhout (The Netherlands), 25-27 June 1990. Psychopharmacology. 101:(suppl):1990;S28.
Lôo H., Malka R., Defrance R., Barrucand D., Benard J.Y., Niox-Rivière H., Raab A., Sarda A., Vachonfrance G., Kamoun A. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology. 19:1988;79-85.
Lôo, H., Ganry, H., Marey, C., Briole, G., Castelnau, D., Charbonnier, J.F., Dachary, J.M., Danion, J.M. Darcourt, G., Capdeville, C., Dufour, H., Souche, A., Escande, M., Favre, J.D., Féline, A., Guelfi, J.D., Léger, J.M., Malauzat, D., Lemoine, P., Malka, R., Olié, J.P., de Praingy, M., Scharbach, H., Scotto, J.C., Tignol, J., Kamoun, A., 1990. Acceptabilité et efficacité thérapeutique de la tianeptine chez 510 patients déprimés traités en un an. JAMA 11 (hors série), 44-53.
Lôo H., Ganry H., Dufour H., Guelfi J.D., Malka R., Olié J.P., Scharbach H., Tignol J., Marey C., Kamoun A. Long-term use of tianeptine in 380 depressed patients. Br. J. Psychiatry. 160:(suppl 15):1992;61-65.
Mennini T., Mocaër E., Garattini S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedeberg's Arch. Pharmacol. 336:1987;478-482.
Mocaër E., Rettori M.C., Kamoun A. Pharmacological antidepressive effects and tianeptine induced 5-HT uptake increase. Clin. Neuropharmacol. 11:(suppl 2):1988;S32-S42.
Montgomery S.A. Selective Serotonin Reuptake Inhibitors in the Acute Treatment of Depression. Bloom F.E., Kupfer D.J. Psychopharmacology - The Fourth Generation of Progress. 1995;Raven Press.
Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 134:1979;382-389.
Ostaptzeff G. Etude contrôlée à double insu versus imipramine de l'efficacité de la tianeptine dans des états dépressifs non psychotiques. Biol. Psychiatry. 5:1981;597-600.
Philipp M., Maier W., Delmo C.D. The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R. Eur. Arch. Psychiatry Clin. Neurosci. 1991. 240:1991;258-265.
Poignant J.C. Etude pharmacologique d'un nouvel antidépresseur: la tianeptine. Biol. Psychiatry. 5:1981;573-578.
Renaud, B., Mocaër, E., Weitsch, A.F., Kato, G., Mennini, T., Garattini, S., 1988. Stimulation of serotonin uptake induced by a new antidepressant. ECNP Constituent meeting, Brussels (Belgium), May 1987, Pharmacopsychiatry 21, 66.
Sternbach H. The Serotonin Syndrome. Am. J. Psychiatry. 148:(6):1991;705-713.
Thiébot M.H., Martin P., Puech A.J. Animal behavioural studies in the evaluation of antidepressant drugs. Br. J. Psychiatry. 160:(suppl 15):1992;44-50.
Weiss C., Gorceix A., Kindynis S., Dimitriu M. Etude contrôlée à double insu versus nomifensine de l'activité et du délai d'action d'un nouvel antidépresseur la tianeptine. Biol. Psychiatry. 5:1981;593-596.
Whitton P.S., Sarna G.S., Curzon G. Effects of tianeptine on stress-induced behavioural deficits and 5-HT dependent behaviour. Psychopharmacology. 104:1991;81-85.